Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FloraSil is a premium vegetal silica supplement derived from the spring horsetail (*Equisetum arvense*) plant, specifically processed to provide a highly bioavailable form of orthosilicic acid. Developed using a unique aqueous extraction method pioneered by Dr. Louis Kervran, the product ensures the retention of naturally occurring bioflavonoids and trace minerals that facilitate the absorption of silica. Silica is an essential trace mineral that acts as a structural component and biochemical cofactor in the synthesis of collagen and keratin, which are the primary structural proteins for hair, skin, nails, and connective tissues. FloraSil is primarily indicated for improving the strength and appearance of hair and nails, supporting skin elasticity, and maintaining the integrity of the dermal layer. Unlike many silica supplements derived from mineral sources like quartz or sand, FloraSil's plant-based origin and water-soluble form offer superior bioavailability for human metabolic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FloraSil.